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Truncation of the Down Syndrome Candidate Gene DYRK1A
in Two Unrelated Patients with Microcephaly
Rikke S. Møller,1,2 Sabine Ku¨bart,3 Maria Hoeltzenbein,3 Babett Heye,4 Ida Vogel,5 Christian P. Hansen,2
Corinna Menzel,3 Reinhard Ullmann,3 Niels Tommerup,1 Hans-Hilger Ropers,3 Zeynep Tu¨mer,1,*
and Vera M. Kalscheuer3
We have identiﬁed and characterized two unrelated patients with prenatal onset of microcephaly, intrauterine growth retardation,
feeding problems, developmental delay, and febrile seizures/epilepsy who both carry a de novo balanced translocation that truncates
the DYRK1A gene at chromosome 21q22.2. DYRK1A belongs to the dual-speciﬁcity tyrosine phosphorylation-regulated kinase
(DYRK) family, which is highly conserved throughout evolution. Given its localization in both the Down syndrome critical region
and in the minimal region for partial monosomy 21, the gene has been studied intensively in animals and in humans, and DYRK1A
has been proposed to be involved in the neurodevelopmental alterations associated with these syndromes. In the present study, we
show that truncating mutations of DYRK1A result in a clinical phenotype including microcephaly.DYRK1A [MIM 600855] is a member of the dual-speciﬁcity
tyrosine phosphorylation-regulated kinase (DYRK) family,
which is evolutionarily conserved and participates in vari-
ous cellular processes.DYRK1Ahasbeen investigated inten-
sively, mainly because of the chromosomal localization of
the gene, DYRK1A, within the Down syndrome critical re-
gion (DSCR [MIM 190685]) on chromosome 21.1 Several
lines of evidence, both in human and in animal models,
suggest that DYRK1A is involved in neurogenesis. The Dro-
sophila ortholog of DYRK1A is the minibrain (mnb) gene,
and its protein product is shown to play an essential role
during postembryonic neurogenesis through regulation of
the number of distinct neuronal cell types.2 The brain of
the adult mutant mnb ﬂy is smaller than that of the wild-
type ﬂy, and the reduction in the number of neuronal cells
is mainly in the optic lobes and in parts of the central brain
hemispheres, resulting in distinct behavioral abnormali-
ties.2 Mice with one functional copy of Dyrk1a (Dyrk1aþ/
mutants) display a brain size 30% smaller than of wild-
type mice, and they show growth retardation, behavioral
defects, and altered motor activity due to dopaminergic
dysfunction.3–5 In humans, DYRK1A has been proposed
to be associatedwithmicrocephaly andmental retardation,
given its localization to the minimal overlapping region
observed in patients with partial monosomy 21.6
Overexpression of DYRK1A in mice leads to increased
brain weight and neuronal size, as well as learning and
memory defects, neurodevelopmental delay, hyperactivity,
and motor abnormalities.7–11 Interestingly, in Down syn-
drome patients the DYRK1A transcript and the protein
product are overexpressed in the brain, which is microce-
phalic and characterized by defective cortical lamination,
reduced cortical neurons, and abnormal synapses.12–15The AmThe Down syndrome critical region of human chromo-
some 21 has been deﬁned on the basis of the analysis of
rare cases of partial trisomy 21, and the studies in human
and animal models suggest that DYRK1A, which is one of
the 20 genes located in this region, is a likely candidate
for the neurodevelopmental alterations associated with
Down syndrome.16 Interestingly, the pyramidal cells,
which comprise 70% of the neurons in the cerebral cortex,
have smaller dendritic arbors, shorter basal dendrites, and
fewer dendritic spines than normal, both inDyrk1aþ/mu-
tants17 and in Ts65Dn mice triallelic for Dyrk1a.18 These
studies with human and animal models, which are mono-
allelic or triallelic for DYRK1A/Dyrk1a/mnb, indicate that
this gene is important in neural plasticity and necessary
for the normal size and development of the brain in a dos-
age-sensitive way. In the present study we show, to our
knowledge for the ﬁrst time, that truncation of the human
DYRK1A gene by translocation breakpoints results in a clin-
ical phenotype including microcephaly.
Patient 1 (Figures 1A–1E) was the ﬁrst child of healthy
nonconsanguineous Danish parents. The family history
was unremarkable. The mother was hospitalized during
pregnancy from week 25 onward due to cervical dilatation
(4 cm). The boy was born by vaginal delivery at 37 weeks.
Birth weight was 2286 g (3 SD), birth length was 45 cm
(3 SD), and head circumference was 29.5 cm (3 SD).
Besides microcephaly, minor dysmorphic features includ-
ing large low-set ears, long philtrum, and micrognathia
were noticed at birth. The neonatal period was complicated
by poor feeding due to diminished sucking reﬂexes. A
systolic murmur was noted, but echocardiography did
not reveal any abnormality. Several incidences of a down-
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were noticed, but cranial ultrasound was normal. He was
released from hospital at 16 days of age. He was hospital-
ized on several occasions due to feeding problems, recur-
rent otitis, and a single septic episode. At the two months
of age, bilateral inguinal hernia was observed. The repeated
downward gaze persisted and was followed by episodes of
hyperextension of the neck. Repeated cranial-ultrasound
examinations didnot revealhydrocephalus or anyother ab-
normality. Brain MRI performed at three months of age
showed, in addition to microcephaly, hypogenesis of the
corpus callosum (Figure 1F). Some of his developmental
milestones were slightly delayed. His ﬁrst eye contact and
ﬁrst smile occurred at three months of age. He started to
crawl at 8.5 months of age, and he walked at 15 months.
His head circumference corresponded to < 3 SD at 8.5
months. At 20 months, he was happy and content. He
was able to play with toys and spoke his ﬁrst few words
during this time. His spatial skills were still limited. His
weight was 10 kg (2 SD), height was 77.5 cm (3 SD),
Figure 1. Clinical Pictures and Labora-
tory Investigations of Patient 1
The pictures were taken when the patient
was 3 months (A), 9 months (B), 14
months (C), and 24 months (D and E) of
age. Magnetic-resonance imaging (F) at
three months of age showed microcephaly
and hypogenesis of corpus callosum. Cyto-
genetic analysis revealed a translocation
with the karyotype 46,XY,t(9;21)(p12;q22)
(G). For mapping of the breakpoints of the
translocation, fluorescence in situ hybrid-
ization (FISH) was carried out with the
use of BAC clones, according to standard
procedures. The BAC clone RP11-315B15,
which contains DYRK1A, spans the chromo-
some 21 breakpoint, as shown by signals
on the normal and the derivative chromo-
somes (H).
and head circumference was 43.2 cm
(< 3 SD). He was diagnosed with
bilateral hypermetropia (þ6 dpt). He
had a total of seven episodes of febrile
convulsions, of a duration of up to
2 min each, induced by bacterial in-
fections and fever. Interictal EEG
was normal. Hand stereotypes (hand-
washing) were observed to occur
when he felt insecure. The patient is
at present 24 months of age.
Cytogenetic analysis revealed a
de novo balanced translocation
t(9;21)(p12;q22) (Figure 1G). The
chromosome 9 breakpoint was map-
ped to 9p11.2 by ﬂuorescence in situ
hybridization (FISH) within the BAC
clone RP11-268E1 covering a gene-empty region with sev-
eral segmental duplications (data not shown). The chro-
mosome 21 breakpoint was mapped to 21q22.2 within
the overlapping region of the BAC clones RP11-315B15
(Figure 1H), RP11-777J19, and RP11-119A10 (chromosome
position: 37,669,622–37,704,000, UCSC March 2006
freeze) (data not shown). The FISH results revealed that
the breakpoint was within the second intron of the
DYRK1A gene14 (Figure 2). Whole-genome array CGH
was carried out with the use of a submegabase-resolution
tiling-path BAC array consisting of the human genome
high-resolution 32 k re-arrayed clone set, the 1 Mb Sanger
set, and a set of 390 subtelomeric clones as described pre-
viously19 and deletions or duplications around the trans-
location breakpoints or elsewhere in the genome were
excluded.
Patient 2 (Figures 3A–3E) was the second child of healthy
nonconsanguineous German parents with uneventful
family history. The older sister is phenotypically normal.1166 The American Journal of Human Genetics 82, 1165–1170, May 2008
Figure 2. The Genomic Region Covered
by the DYRK1A Gene
The locations of the chromosomal break-
points of the translocation patients are
indicated by vertical arrows. The DYRK1A
gene is organized in 17 exons (boxes) and
has two transcription start sites, with
exon 1 and exon 2 as alternative first exons.
The use of these alternative start sites
yields two major transcripts, DYRK1Aa
(5182 nt) and DYRK1Ab (5287 nt), which
are both truncated by the translocation
breakpoints in patients 1 and 2. The bracket
indicates that exon 3 is alternatively
spliced. The chromosome band and base-
pair positions are shown above the figure.The pregnancy was complicated by polyhydramnios. Mi-
crocephaly and growth retardation were noticed at the
28th week of gestation. The patient was born at term, and
her birth weight was 2400 g (3 SD), birth length was
47 cm (2 SD), and head circumference was 30 cm (3
SD). Difﬁculties in feeding required enteral feeding, and
feeding problems persisted during infancy. Gross motor
development was delayed: She sat alone at 15 months of
age and walked at two years of age. At one year of age,
the ﬁrst febrile convulsion was noted during a severe bron-
chiopulmonary infection. Antiepileptic treatment with
primidone was started after the third generalized tonic-
clonic seizure at 19 months of age. Additional focal sei-
zures and further EEG abnormalities at three years of age
led to therapy with valproate and ethosuccimide. Reduc-
tion of antiepileptic medication was not tolerated. At 21
months of age, height was 85 cm (mean for age), weight
was 9270 g (3 SD), and head circumference was 41 cm
(< 3 SD). Echocardiography at 18 months of age showed
a small ventricular septal defect and mild aortic-valve in-
sufﬁciency. At 10.5 years of age, height was 130 cm (1.5
SD), weight was 21 kg (3 SD), and head circumference
was 45.9 cm (< 3 SD). On clinical reexamination at
13 years of age, the patient was severely mentally retarded
and did not have any speech. Her height was 142 cm
(1.5 SD), her weight was 26 kg (3 SD), and her head
circumference was 46.5 cm (< 3 SD). She had mild dys-
morphic facial features, including asymmetrical head, ﬂat
philtrum, small upper lip, large ears, and abnormal whorls
of hair. She had pectus excavatum, kyphosis, and slight
scoliosis, and her skin was very thin. Terminal phalanges
of hands and feet were shortened and broad. Feeding of
the patient continued to be extremely difﬁcult. A CT
scan of her brain at seven years of age showed head asym-
metry with left occipital ﬂattening and mild enlargement
of the ventricles (Figure 3F). MRI of the brain at 12 years
of age did not reveal further structural changes (Figures
3G and 3H).
Cytogenetic analysis indicated a de novo balanced trans-
location t(2;21)(q22;q22) (Figure 3I). Using FISH analysis,
we mapped the chromosome 21 breakpoint within theThe AmYAC clone 662A10 (Figure 3J), which contained the
DYRK1A gene, and the chromosome2breakpointwasmap-
pedwithin theYACclone670G1 (datanot shown).Cloning
and sequence analysis of the junction fragments indicated
that the chromosome 2 breakpoint was within intron
39 of the putative tumor-suppressor gene, LRP1B (low
density lipoprotein-related protein 1B [MIM608766]) (after
nucleotide 141,257,981 of chromosome 2, UCSC March
2006 freeze) (data not shown). Mapping of the chromo-
some 21 breakpoint by Southern-blot analysis (Figure 3K)
followed by cloning and sequencing of the junction frag-
ment indicated that DYRK1A was disrupted in intron
6 following exon 6a/6b (after nucleotide 37,779,572 of
chromosome 21, UCSC March 2006 freeze) (Figure 3).
Whole-genome BAC-array CGH and 244 K oligonucleotide
CGH array (Agilent) showed a 590 kb duplication at Xp22
(chromosome position: 13,895,000–14,489,000, UCSC
March 2006 freeze) comprising the GEMIN8 gene (Gen-
Bank; see Web Resources section) and the ﬁrst exon of the
glycine receptor gene (GLRA2, MIM 305990) (data not
shown). Parental origin of this duplication could not be
investigated because DNA samples from the parents were
not available.
In two unrelated translocation carriers, the DYRK1A
gene was truncated by the chromosome 21 breakpoints.
The features of microcephaly, intrauterine growth retar-
dation, postnatal feeding problems, and large ears observed
in these patients resemble the phenotypes of the patients
with partial monosomy 21.6,20–22 In partial monosomy
21 patients, the common deleted region for microcephaly
andmental retardation has beennarrowed down to a 1.2Mb
region ﬂanked by the markers D21S334 and D21S55
(chromosome position: 36,737,455-38,012,252).6 This
region covers ten genes, including DYRK1A, which has
been suggested as the candidate gene for the common neu-
rological phenotypes of these patients. Our ﬁndings there-
fore strongly suggest that haploinsufﬁciency of DYRK1A is
causative for the common features, including microceph-
aly, observed in partial monosomy 21 patients. These ﬁnd-
ings, together with the brain phenotypes of ﬂy (mnb) and
mouse (Dyrk1aþ/) mutants with one functional copy oferican Journal of Human Genetics 82, 1165–1170, May 2008 1167
Dyrk1a, render this evolutionarily conserved gene as a
microcephaly gene in humans.
The two patients presented here have overlapping clini-
cal phenotypes including microcephaly, large ears, intra-
uterine growth retardation, postnatal feeding problems,
and febrile seizures, but they have different degrees of
developmental delay, and patient 2 is more severely
Figure 3. Clinical Pictures and Labora-
tory Investigations of Patient 2
The pictures were taken when the patient
was 12 years of age. She has asymmetry
of the head, flat philtrum, small upper
lip, abnormal whorls of hair (A); micro-
cephaly and large ears (B); pectus excava-
tum (C); and shortened and broad terminal
phalanges of the hands and feet (D and E).
Computerized tomography (F) at seven
years of age and magnetic-resonance imag-
ing (G and H) at 12 years of age showed mi-
crocephaly with head asymmetry and mild
enlargement of the ventricles. Cytogenetic
analysis revealed a translocation with the
karyotype 46,XX,t(2;21)(q22;q22) (I). For
mapping of the breakpoints of the translo-
cation, FISH was carried out with the use of
YAC, BAC, PAC, or cosmid clones according
to standard procedures. The YAC clone
662A10, which contains DYRK1A, spans
the chromosome 21 breakpoint, as shown
by signals on the normal and the derivative
chromosomes (J). Chromosome 21 break-
point was fine mapped with Southern-blot
hybridization (K). Genomic DNA from the
patient (‘‘P’’) and the control (‘‘C’’) was di-
gested with three restriction enzymes and
hybridized with the breakpoint-spanning
probe (chromosome position: 37,778,809–
37,780,325). Aberrant bands representing
the junction fragments are indicated by
arrowheads.
affected than patient 1. A plausible
explanation might be disruption of
LRP1B by the chromosome 2 break-
point in patient 2, but given that
Lrp1b/ mice appear normal,23 it is
unlikely that this aberration has a ma-
jor impact on the clinical phenotype.
Patient 2 also has a duplication of un-
known origin at Xp22. The duplica-
tion included the GEMIN8 gene,
which has an essential role in organi-
zation and function of the survival-
motor-neuron complex.24 Even
though it is unlikely that the duplica-
tion of X chromosome sequences in
a female would cause an abnormal
phenotype, the possibility that a hy-
pothetically increased dosage of GEMIN8 in the critical tis-
sues might affect the disease severity cannot be excluded.
In summary, our ﬁnding of two unrelated patients with
microcephaly and truncation of DYRK1A demonstrates
that this gene plays a critical role in human brain develop-
ment and that haploinsufﬁciency of DYRK1A causes
microcephaly in humans, probably through mechanisms1168 The American Journal of Human Genetics 82, 1165–1170, May 2008
that control neural differentiation. In addition, our results,
together with previous ﬁndings ofDYRK1A overexpression
in brains of Down syndrome patients, strongly suggest
that in humans the dosage of the associated kinase needs
to be very tightly regulated and that both an increase
and a decrease in the dosage could result in a disease
phenotype.
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